Literature DB >> 23703484

[Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1)].

C Scheidt-Nave1, Y Du, H Knopf, A Schienkiewitz, T Ziese, E Nowossadeck, A Gößwald, M A Busch.   

Abstract

Interview and laboratory data from the first wave of the German health interview and examination survey for adults (DEGS1) from 2008 to 2011 were used to provide current estimates of the prevalence of dyslipidemia which are representative of the population in Germany 18 to 79 years of age. A total of 56.6 % of men and 60.5 % of women 18 to 79 years have elevated serum total cholesterol concentrations in excess of the currently recommended threshold of 190 mg/dL; 17.9 % of men and 20.3 % of women have highly elevated total cholesterol concentrations ≥ 240 mg/dL. A total of 19.3 % of men and 3.6 % of women have high density lipoprotein cholesterol concentrations below 40 mg/dL. The overall prevalence of dyslipidemia (total cholesterol ≥ 190 mg/dL or medical diagnosis of dyslipidemia) is 64.5 % for men and 65.7 % for women. Of these, more than half of both men and women have previously undiagnosed dyslipidemia. Among persons with known dyslipidemia, 30.8% take lipid-lowering medication. Dyslipidemia is widely prevalent among adults in Germany. More in-depth analyses will examine time trends in the prevalence of dyslipidemia in Germany and in an international comparison. An English full-text version of this article is available at SpringerLink as supplemental.

Entities:  

Mesh:

Year:  2013        PMID: 23703484     DOI: 10.1007/s00103-013-1670-0

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  26 in total

1.  From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Authors:  Eva Barrenberg; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2017-03-28       Impact factor: 2.953

2.  Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.

Authors:  Birgit Knebel; Stefan Lehr; Onno E Janssen; Susanne Hahn; Sylvia Jacob; Ulrike Nitzgen; Dirk Müller-Wieland; Jorg Kotzka
Journal:  Mol Biol Rep       Date:  2016-11-22       Impact factor: 2.316

3.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.

Authors:  Saro H Armenian; Wassim Chemaitilly; Marcus Chen; Eric J Chow; Christine N Duncan; Lee W Jones; Michael A Pulsipher; Alan T Remaley; Alicia Rovo; Nina Salooja; Minoo Battiwalla
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-30       Impact factor: 5.742

Review 4.  Teachers' Health.

Authors:  Klaus Scheuch; Eva Haufe; Reingard Seibt
Journal:  Dtsch Arztebl Int       Date:  2015-05-15       Impact factor: 5.594

Review 5.  [Dyslipidemias : Diagnostics and management].

Authors:  D Sinning; U Landmesser
Journal:  Herz       Date:  2017-09       Impact factor: 1.443

6.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

Review 7.  Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.

Authors:  Z DeFilipp; R F Duarte; J A Snowden; N S Majhail; D M Greenfield; J L Miranda; M Arat; K S Baker; L J Burns; C N Duncan; M Gilleece; G A Hale; M Hamadani; B K Hamilton; W J Hogan; J W Hsu; Y Inamoto; R T Kamble; M T Lupo-Stanghellini; A K Malone; P McCarthy; M Mohty; M Norkin; P Paplham; M Ramanathan; J M Richart; N Salooja; H C Schouten; H Schoemans; A Seber; A Steinberg; B M Wirk; W A Wood; M Battiwalla; M E D Flowers; B N Savani; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2016-08-22       Impact factor: 5.483

8.  Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: the German National Health Interview and Examination Survey.

Authors:  Phillip J Tully; Bernhard T Baune
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-10-29       Impact factor: 4.328

Review 9.  Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease.

Authors:  Peter Mirtschink; Cholsoon Jang; Zoltan Arany; Wilhelm Krek
Journal:  Eur Heart J       Date:  2018-07-07       Impact factor: 29.983

10.  Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis.

Authors:  Toni Meier; Karolin Senftleben; Peter Deumelandt; Olaf Christen; Katja Riedel; Martin Langer
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.